Extending the QALY framework for HTA: exploring the linkages among benefit-risk assessment, stratified medicines, performance-based risk-sharing, and comparative effectiveness research
Thursday 7 March 2013, 2.00PM to 3.15pm
Speaker(s): Lou Garrison, PhD OHE Visiting Senior Research Fellow, 2012-3, Office of Health Economics, London, UK. Professor and Associate Director, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington
Hosted by: Centre for Health Economics (CHE)
For further information:
Please contact: Kerry Atkinson ext 1403 or email kerry.atkinson@york.ac.uk
Location: ARRC Auditorium A/RC/014